astemizole has been researched along with Angioneurotic Edema in 3 studies
Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Astemizole, one of the newer generation of nonsedating antihistamines, was evaluated in a double-blind study of forty-six patients who had chronic idiopathic urticaria with or without angioedema; most had severe disease." | 9.06 | Controlled clinical assessment of astemizole in the treatment of chronic idiopathic urticaria and angioedema. ( Kailasam, V; Mathews, KP, 1987) |
| "20 patients, 12 suffering from chronic urticaria, 2 from acute urticaria, 1 from pressure urticaria, 2 from cold urticaria and 3 from urticaria factitia were treated in an open pilot study with the new H1-antihistamine Astemizole." | 7.67 | [Treatment of urticaria with the new H1 antihistaminic astemizole--with special reference to the time of onset of effect and maximum effect]. ( Kurz, K, 1986) |
| "Astemizole, one of the newer generation of nonsedating antihistamines, was evaluated in a double-blind study of forty-six patients who had chronic idiopathic urticaria with or without angioedema; most had severe disease." | 5.06 | Controlled clinical assessment of astemizole in the treatment of chronic idiopathic urticaria and angioedema. ( Kailasam, V; Mathews, KP, 1987) |
| "20 patients, 12 suffering from chronic urticaria, 2 from acute urticaria, 1 from pressure urticaria, 2 from cold urticaria and 3 from urticaria factitia were treated in an open pilot study with the new H1-antihistamine Astemizole." | 3.67 | [Treatment of urticaria with the new H1 antihistaminic astemizole--with special reference to the time of onset of effect and maximum effect]. ( Kurz, K, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soter, NA | 1 |
| Kurz, K | 1 |
| Kailasam, V | 1 |
| Mathews, KP | 1 |
1 trial available for astemizole and Angioneurotic Edema
| Article | Year |
|---|---|
Controlled clinical assessment of astemizole in the treatment of chronic idiopathic urticaria and angioedema.
Topics: Adult; Angioedema; Astemizole; Benzimidazoles; Chronic Disease; Clinical Trials as Topic; Double-Bli | 1987 |
2 other studies available for astemizole and Angioneurotic Edema
| Article | Year |
|---|---|
Treatment of urticaria and angioedema: low-sedating H1-type antihistamines.
Topics: Angioedema; Astemizole; Benzhydryl Compounds; Benzimidazoles; Cetirizine; Cyproheptadine; Histamine | 1991 |
[Treatment of urticaria with the new H1 antihistaminic astemizole--with special reference to the time of onset of effect and maximum effect].
Topics: Adolescent; Adult; Angioedema; Astemizole; Benzimidazoles; Female; Histamine H1 Antagonists; Humans; | 1986 |